Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine 2% Pharmacopuncture at GB20 for Migraine
NCT07067853Completed
- Sponsor
- Universitas Indonesia
- Start
- Sep 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of lidocaine in migraine (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Frequency of migraine attacks at 8 weeks, Duration of migraine attacks at 8 weeks and 4 more. Started Sep 2025; status: completed.
02
Drugs
lidocaine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07067853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07067853.